{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:02:34Z","timestamp":1781715754164,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute of Health","award":["R01-NS097800"],"award-info":[{"award-number":["R01-NS097800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02350-9","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T11:03:13Z","timestamp":1615460593000},"page":"3374-3387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Verapamil Prevents Development of Cognitive Impairment in an Aged Mouse Model of Sporadic Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Heba A.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifudeen","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnoush","family":"Mirzahosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-1342","authenticated-orcid":false,"given":"Tauheed","family":"Ishrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"2350_CR1","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1007\/s12035-020-01964-9","volume":"57","author":"HA Ahmed","year":"2020","unstructured":"Ahmed HA, Ishrat T (2020) The Brain AT2R \u2014 a Potential Target for Therapy in Alzheimer\u2019s Disease and Vascular Cognitive Impairment : a Comprehensive Review of Clinical and Experimental Therapeutics. Mol Neurobiol 57:3458\u20133484","journal-title":"Mol Neurobiol"},{"key":"2350_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12068","volume":"16","author":"Alzheimer\u2019s Association","year":"2020","unstructured":"Alzheimer\u2019s Association (2020) Alzeheimer\u2019s Facts and Figures. Annual report released by the Alzheimer\u2019s Association. Alzheimer Dement 16:391\u2013460","journal-title":"Alzheimer Dement"},{"issue":"1","key":"2350_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2018.07.216","volume":"15","author":"KB Rajan","year":"2019","unstructured":"Rajan KB, Weuve J, Barnes LL, Wilson RS, Evans DA (2019) Prevalence and incidence of clinically diagnosed Alzheimer\u2019s disease dementia from 1994 to 2012 in a population study. Alzheimers Dement 15(1):1\u20137","journal-title":"Alzheimers Dement"},{"key":"2350_CR4","first-page":"383","volume":"12","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Mudher A (2018) Alzheimer\u2019s Disease and Type 2 Diabetes : A Critical Assessment of the Shared Pathological Traits. Front Endocrinol 12:383\u2013405","journal-title":"Front Endocrinol"},{"issue":"7","key":"2350_CR5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4103\/1673-5374.160076","volume":"10","author":"PK Kamat","year":"2015","unstructured":"Kamat PK (2015) Streptozotocin induced Alzheimer \u2019 s disease like changes and the underlying neural degeneration and regeneration mechanism. Neural Regen Res 10(7):1050\u20131052","journal-title":"Neural Regen Res"},{"issue":"2","key":"2350_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12035-012-8375-5","volume":"47","author":"Y Chen","year":"2013","unstructured":"Chen Y, Liang Z, Blanchard J, Dai C-L, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K et al (2013) and GC-X. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer\u2019s disease: Similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol 47(2):711\u2013725","journal-title":"Mol Neurobiol"},{"key":"2350_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2009.04.010","volume":"1281","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P et al (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer\u2019s type. Brain Res 1281:117\u2013127","journal-title":"Brain Res"},{"key":"2350_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3233\/JAD-2009-1184","volume":"18","author":"M Salkovic-Petrisic","year":"2009","unstructured":"Salkovic-Petrisic M, Osmanovic J, Gr\u00fcnblatt E, Riederer P, Hoyer S (2009) Modeling sporadic alzheimer\u2019s disease : the insulin resistant brain state generates multiple long-term morphobiological abnormalities inclusive hyperphosphorylated tau protein and Modeling sporadic alzheimer\u2019s disease : the insulin. J Alzheimers Dis 18:729\u2013750","journal-title":"J Alzheimers Dis"},{"issue":"1\u20135","key":"2350_CR9","first-page":"1","volume":"156","author":"NAPA","year":"2012","unstructured":"NAPA (2012) National Alzheimer\u2019s Project Act (NAPA ). Congr Record 156(1\u20135):1\u201333","journal-title":"Congr Record"},{"issue":"11","key":"2350_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrd3869","volume":"11","author":"A Corbett","year":"2012","unstructured":"Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C et al (2012) Drug repositioning for Alzheimer\u2019s disease. Nature reviews |. Drug Discov 11(11):833\u2013846","journal-title":"Drug Discov"},{"key":"2350_CR11","unstructured":"(1998) VERAPAMIL. [Package Insert]. ELAN HOLDINGS, INC Gainesville. 1\u201312"},{"key":"2350_CR12","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/head.13603","volume":"59","author":"AS Petersen","year":"2019","unstructured":"Petersen AS, Barloese MCJ, Snoer A, Soerensen AMSJR (2019) Verapamil and Cluster Headache: Still a Mystery. A Narrative Review of Efficacy, Mechanisms and Perspectives. Headache. 59:1198\u20131211","journal-title":"Headache."},{"issue":"May","key":"2350_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3389\/fphar.2020.00562","volume":"11","author":"N Popovic","year":"2020","unstructured":"Popovic N, Morales-Delgado N, Mena DV, Alonso A, Mart\u00ednez MP (2020) Verapamil and Alzheimer\u2019s Disease : Past , Present , and Future. Front Pharmacol 11(May):562","journal-title":"Front Pharmacol"},{"key":"2350_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11095-017-2276-2","volume":"35","author":"MAB Melone","year":"2018","unstructured":"Melone MAB, Dato C, Paladino S, Coppola C, Trebini C, Giordana MTPL (2018) Verapamil Inhibits Ser202\/Thr205 Phosphorylation of Tau by Blocking TXNIP\/ROS\/p38 MAPK Pathway. Pharm Res 35:44\u201348","journal-title":"Pharm Res"},{"issue":"6","key":"2350_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuhill IC, Emerson MAD, Altman DG (2010) Improving Bioscience Research Reporting : The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 8(6):6\u201310","journal-title":"PLoS Biol"},{"issue":"7","key":"2350_CR16","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia S, Alam S, Avey MT, Bake M, Browne WJ et al (2020) The ARRIVE guidelines 2 . 0 : Updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410\u2013e3000421","journal-title":"PLoS Biol"},{"issue":"1","key":"2350_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-018-1262-x","volume":"15","author":"HA Ahmed","year":"2018","unstructured":"Ahmed HA, Ishrat T, Pillai B, Fouda AY, Sayed MA, Eldahshan W, Waller JL, Ergul A et al (2018) AS modulation prevents progressive cognitive impairment after experimental stroke: A randomized, blinded preclinical trial. J Neuroinflammation 15(1):229\u2013245","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2350_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopmanc DS, Chertkowd H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269","journal-title":"Alzheimers Dement"},{"key":"2350_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbr.2018.10.010","volume":"359","author":"HA Ahmed","year":"2019","unstructured":"Ahmed HA, Ishrat T, Pillai B, Bunting KM, Vazdarjanova WJL, Ergul A, Fagan SC (2019) Angiotensin receptor ( AT2R ) agonist C21 prevents cognitive decline after permanent stroke in aged animals \u2014 A randomized double- blind pre-clinical study. Behav Brain Res 359:560\u2013569","journal-title":"Behav Brain Res"},{"key":"2350_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1755-5949.2012.00362.x","volume":"18","author":"JX Ma","year":"2012","unstructured":"Ma JX, Hou J-y, Yan W-w, Sun H-j, Huang Y, Jin S-w, Wang L, Hu Y et al (2012) Protective Effect of Carnosine on Subcortical Ischemic Vascular Dementia in Mice. CNS Neurosci Ther 18:745\u2013753","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2350_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1101\/lm.89805","volume":"12","author":"M Wietrzych","year":"2005","unstructured":"Wietrzych M, Meziane H, Sutter A, Ghyselinck N, Chapman P, Krezel W (2005) Working memory deficits in retinoid X receptor gama-deficient mice. Learn Mem 12(3):318\u2013326","journal-title":"Learn Mem"},{"key":"2350_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G (2012) The novel object recognition memory : neurobiology , test procedure , and its modifications. Cogn Process 13:93\u2013110","journal-title":"Cogn Process"},{"key":"2350_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2017.12.007","volume":"346","author":"HA Ahmed","year":"2018","unstructured":"Ahmed HA, Ishrat T, Pillai B, Bunting KM, Patel A, Vazdarjanova A, Waller JL, Arbab AS et al (2018) Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals \u2013 A randomized double-blind pre-clinical study. Behav Brain Res 346:29\u201340","journal-title":"Behav Brain Res"},{"key":"2350_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury GE, Landreth GE, Frederic B, Feinstein DL, Jacobs AH, Tony WS et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405","journal-title":"Lancet Neurol"},{"key":"2350_CR25","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00702-018-1928-7","volume":"125","author":"MFZ Villar","year":"2018","unstructured":"Villar MFZ, Hanotte JL, Lockhart EF, Tr\u00edpodi LS, Morel GR, Reggiani PC (2018) Intracerebroventricular streptozotocin induces impaired Barnes maze spatial memory and reduces astrocyte branching in the CA1 and CA3 hippocampal regions. J Neural Transm 125:1787\u20131803","journal-title":"J Neural Transm"},{"key":"2350_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbr.2017.01.034","volume":"323","author":"K Rekik","year":"2017","unstructured":"Rekik K, Franc\u00e9s B, Valet P, Dray C, Florian C (2017) Cognitive deficit in hippocampal-dependent tasks in Werner syndrome mouse model. Behav Brain Res 323:68\u201377","journal-title":"Behav Brain Res"},{"key":"2350_CR27","first-page":"155","volume":"215","author":"AMM Oliveira","year":"2010","unstructured":"Oliveira AMM, Hawk JD, Abel T, Havekes R (2010) Post-training reversible inactivation of the hippocampus enhances novel object recognition memory. Cold Spring Harbor Lab 215:155\u2013160","journal-title":"Cold Spring Harbor Lab"},{"issue":"12","key":"2350_CR28","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/nprot.2013.155","volume":"8","author":"M Leger","year":"2013","unstructured":"Leger M, Quiedeville A, Bouet V, Haelewyn B, Boulouard M, Schumann-Bard P, Freret T (2013) Object recognition test in mice. Nat Protoc 8(12):2531\u20132537","journal-title":"Nat Protoc"},{"key":"2350_CR29","first-page":"476","volume":"2012","author":"E Moscardo","year":"2012","unstructured":"Moscardo E, Salvetti B, Becchi S, Bertini G, Fabene PF (2012) The Novel Object Recognition Test in Rodents : Which Are the Essential Methodological Aspects? Proc Meas Behav 2012:476\u2013478","journal-title":"Proc Meas Behav"},{"issue":"April","key":"2350_CR30","first-page":"1","volume":"5","author":"SJ Webster","year":"2014","unstructured":"Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ (2014) Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5(April) 88:1\u201323","journal-title":"Front Genet"},{"key":"2350_CR31","first-page":"25","volume":"2012","author":"A Kouwenberg","year":"2012","unstructured":"Kouwenberg A, Martin GM, Skinner DM, Thorpe CM, Walsh CJ (2012) Spontaneous Object Recognition in Animals : A Test of Episodic Memory. Adv Object Recog Syst 2012:25\u201338","journal-title":"Adv Object Recog Syst"},{"key":"2350_CR32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","volume":"58","author":"S Chiu","year":"2008","unstructured":"Chiu S, Chen C, Cline HT (2008) Article Insulin Receptor Signaling Regulates Synapse Number , Dendritic Plasticity, and Circuit Function In Vivo. Neuron. 58:708\u2013719","journal-title":"Neuron."},{"key":"2350_CR33","doi-asserted-by":"publisher","unstructured":"Ismael S, Nasoohi S, Yoo A, Li L, Aslam K, Khan MM et al (2020) TXNIP regulates age-associated neuroinflammation: Implication in Alzheimer\u2019s disease. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-25794\/v1","DOI":"10.21203\/rs.3.rs-25794\/v1"},{"key":"2350_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","volume":"118","author":"T Arendt","year":"2009","unstructured":"Arendt T (2009) Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol 118:167\u2013179","journal-title":"Acta Neuropathol"},{"key":"2350_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","volume":"12","author":"M Colom-cadena","year":"2020","unstructured":"Colom-cadena M, Spires-jones T, Zetterberg H, Blennow K, Caggiano A, Dekosky S, Fillit H, Harrison JE et al (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease. Alzheimers Res Ther 12:21\u201332","journal-title":"Alzheimers Res Ther"},{"issue":"17","key":"2350_CR36","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1523\/JNEUROSCI.19-17-07300.1999","volume":"19","author":"M Abbott","year":"1999","unstructured":"Abbott M, Wells DG, Fallon JR (1999) The Insulin Receptor Tyrosine Kinase Substrate p58 \/ 53 and the Insulin Receptor Are Components of CNS Synapses. J Neurosci 19(17):7300\u20137308","journal-title":"J Neurosci"},{"issue":"July","key":"2350_CR37","first-page":"1","volume":"13","author":"M Spinelli","year":"2019","unstructured":"Spinelli M, Fusco S, Grassi C (2019) Brain Insulin Resistance and Hippocampal Plasticity : Mechanisms and Biomarkers of Cognitive Decline. Front Neurosci 13(July) 788:1\u201313","journal-title":"Front Neurosci"},{"key":"2350_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pbb.2013.11.035","volume":"117","author":"S Rai","year":"2014","unstructured":"Rai S, Kamat PK, Nath C, Shukla R (2014) Pharmacology , Biochemistry and Behavior Glial activation and post-synaptic neurotoxicity: The key events in Streptozotocin ( ICV ) induced memory impairment in rats. Pharmacol Biochem Behav 117:104\u2013117","journal-title":"Pharmacol Biochem Behav"},{"key":"2350_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-015-4095-7","volume":"233","author":"A Kumar","year":"2016","unstructured":"Kumar A, Mishra J (2016) Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction. Psychopharmacology. 233:137\u2013152","journal-title":"Psychopharmacology."},{"key":"2350_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11011-019-00498-x","volume":"35","author":"S Ponne","year":"2020","unstructured":"Ponne S (2020) Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury \u2013 A potential therapeutic agent for Alzheimer\u2019s Disease. 2020. Metab Brain Dis 35:503\u2013515","journal-title":"Metab Brain Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02350-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02350-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02350-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T02:25:39Z","timestamp":1625538339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02350-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2350"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02350-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving animals were approved by the institutional animal Committee at UTHSC in full accordance with the ethical guidelines of the National Institutes of Health for the care and use of laboratory animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}